(Q34312746)

1 August 2017

title

Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study (English)

1 reference

1 August 2017

0 references

0 references

1 reference

7

Truls Østbye

1 reference

1 August 2017

1

Neela D Goswami

1 reference

1 August 2017

Lara Beth Gadkowski

2

1 reference

1 August 2017

Carla Piedrahita

3

1 reference

1 August 2017

Deborah Bissette

4

1 reference

1 August 2017

Marshall Alex Ahearn

5

1 reference

1 August 2017

Michela L M Blain

6

1 reference

1 August 2017

Jussi Saukkonen

8

1 reference

1 August 2017

Jason E Stout

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

21 June 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

page(s)

468

1 reference

describes a project that uses

1 August 2017

ArcGIS

object named as

ArcGIS

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

ArcGIS

0 references

cites work

Formulation and evaluation of antisebum secretion effects of sea buckthorn w/o emulsion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Medication adherence in Hispanics to latent tuberculosis treatment: a literature review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Treatment of latent tuberculosis infection: An update

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Directly observed therapy for treating tuberculosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Predictors of failure to complete treatment for latent tuberculosis infection.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Factors associated with the treatment of latent tuberculosis infection among health-care workers at a midwestern teaching hospital.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Incentives vs outreach workers for latent tuberculosis treatment in drug users

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

An incentive in tuberculosis preventive therapy for an inner city population.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Use of Isoniazid for Latent Tuberculosis Infection in a Public Health Clinic

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-12-468

Adherence to treatment of latent tuberculosis infection in a clinical population in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-12-468

Health care workers and the initiation of treatment for latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-12-468

Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Latent TB infection treatment acceptance and completion in the United States and Canada

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438075

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-12-468

Predicting Non-Completion of Treatment for Latent Tuberculous Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-12-468

Tuberculosis knowledge, attitudes, and beliefs among North Carolinians at increased risk of infection

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22720842

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2458-12-468

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference